Drug recall · October 6, 2021
Lyrica CR recall
Why: Failed Dissolution Specifications
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lyrica CR (pregabalin) extended release tablets, 330 mg, 30-count bottles, Rx only, Distributed by Parke-Davis Division of Pfizer Inc., NY, NY 10017, NDC 0071-1029-01
- Lots / codes
Lot #: DN5396, EP9726, EK2417, Exp. Date August 2022
- Quantity
- 9,515 bottles
- Company
- Viatris, Morgantown, WV
- Distribution
- Nationwide within the United States
- Initiated
- August 23, 2021 · Voluntary: Firm initiated
- Classified
- September 24, 2021
- Reported
- October 6, 2021
- Ended
- September 7, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Pregabalin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.